Brain insulin resistance at the crossroads of metabolic and cognitive disorders in humans

Physiological Reviews

Volumn 96, Issue 4, 2016, Pages 1169-1209

  Kullmann, Stephanie ^a,b   Heni, Martin ^a,b   Hallschmid, Manfred ^a,b   Fritsche, Andreas ^a,b   Preissl, Hubert ^a,b   Häring, Hans Ulrich ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIDIABETIC AGENT; CANNABINOID 2 RECEPTOR; GLUCOSE; INSULIN; INSULIN DETEMIR; INSULIN RECEPTOR SUBSTRATE 1; MELANOCORTIN 4 RECEPTOR;

AGING; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; BRAIN LEVEL; BRAIN REGION; COGNITIVE DEFECT; CORPUS STRIATUM; DEMENTIA; DEVELOPMENTAL DISORDER; DIET RESTRICTION; EMOTIONALITY; FAT MASS; FEEDING BEHAVIOR; FETAL BRAIN; FRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; LIPOLYSIS; LIVER; LOCOMOTION; MAGNETOENCEPHALOGRAPHY; MEMORY; METABOLIC DISORDER; MORBID OBESITY; NEUROIMAGING; NEUROPATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN METABOLISM; RISK FACTOR; SEX DIFFERENCE; SMELLING; THERMOGENESIS; WEIGHT REDUCTION; BRAIN; METABOLISM; PHYSIOLOGY;

AGING; BRAIN; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE; OBESITY;

EID: 84983786153     PISSN: 00319333     EISSN: 15221210     Source Type: Journal    
DOI: 10.1152/physrev.00032.2015     Document Type: Article

References (404)

1. Air EL, Benoit SC, Blake Smith KA, Clegg DJ, Woods SC. Acute third ventricular administration of insulin decreases food intake in two paradigms. Pharmacol Biochem Behav 72: 423-429, 2002.
2. Air EL, Benoit SC, Clegg DJ, Seeley RJ, Woods SC. Insulin and leptin combine additively to reduce food intake and body weight in rats. Endocrinology 143: 2449-2452, 2002.
3. Akintola AA, van Heemst D. Insulin, aging, and the brain: mechanisms and implications. Front Endocrinol 6: 13, 2015.
4. Almind K, Inoue G, Pedersen O, Kahn CR. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest 97: 2569-2575, 1996.
5. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87: 2246-2252, 1991.
6. Anthony K, Reed LJ, Dunn JT, Bingham E, Hopkins D, Marsden PK, Amiel SA. Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome? Diabetes 55: 2986-2992, 2006.
7. Apostolova LG, Hwang KS, Andrawis JP, Green AE, Babakchanian S, Morra JH, Cummings JL, Toga AW, Trojanowski JQ, Shaw LM, Jack CR Jr, Petersen RC, Aisen PS, Jagust WJ, Koeppe RA, Mathis CA, Weiner MW, Thompson PM, Alzheimer’s Disease Neuroimaging. 3D. PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging 31: 1284-1303, 2010.
8. Arbelaez AM, Su Y, Thomas JB, Hauch AC, Hershey T, Ances BM. Comparison of regional cerebral blood flow responses to hypoglycemia using pulsed arterial spin labeling and positron emission tomography. PLoS One 8: e60085, 2013.
9. Arvanitakis Z, Wilson RS, Bennett DA. Diabetes mellitus, dementia, and cognitive function in older persons. J Nutr Health Aging 10: 287-291, 2006.
10. Arvanitakis Z, Wilson RS, Li Y, Aggarwal NT, Bennett DA. Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care 29: 560-565, 2006.
11. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 68: 51-57, 2011.
12. Banks WA, Jaspan JB, Huang W, Kastin AJ. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides 18: 1423-1429, 1997.
13. Banks WA, Owen JB, Erickson MA. Insulin in the brain: there and back again. Pharmacol Ther 136: 82-93, 2012.
14. Barnes J, Bartlett JW, van de Pol LA, Loy CT, Scahill RI, Frost C, Thompson P, Fox NC. A meta-analysis of hippocampal atrophy rates in Alzheimer’s disease. Neurobiol Aging 30: 1711-1723, 2009.
15. Baskin DG, Brewitt B, Davidson DA, Corp E, Paquette T, Figlewicz DP, Lewellen TK, Graham MK, Woods SG, Dorsa DM. Quantitative autoradiographic evidence for insulin receptors in the choroid plexus of the rat brain. Diabetes 35: 246-249, 1986.
16. Baskin DG, Porte D Jr, Guest K, Dorsa DM. Regional concentrations of insulin in the rat brain. Endocrinology 112: 898-903, 1983.
17. Baura GD, Foster DM, Porte D Jr, Kahn SE, Bergman RN, Cobelli C, Schwartz MW. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest 92: 1824-1830, 1993.
18. Begg DP. Insulin transport into the brain and cerebrospinal fluid. Vitamins Hormones 98: 229-248, 2015.
19. Benedict C, Brede S, Schioth HB, Lehnert H, Schultes B, Born J, Hallschmid M. Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men. Diabetes 60: 114-118, 2011.
20. Benedict C, Brooks SJ, Kullberg J, Burgos J, Kempton MJ, Nordenskjold R, Nylander R, Kilander L, Craft S, Larsson EM, Johansson L, Ahlstrom H, Lind L, Schioth HB. Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly. Diabetes Care 35: 488-494, 2012.
21. Benedict C, Dodt C, Hallschmid M, Lepiorz M, Fehm HL, Born J, Kern W. Immediate but not long-term intranasal administration of insulin raises blood pressure in human beings. Metabolism 54: 1356-1361, 2005.
22. Benedict C, Frey WH 2nd, Schioth HB, Schultes B, Born J, Hallschmid M. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments. Exp Gerontol 46: 112-115, 2011.
23. Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm HL, Born J, Kern W. Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29: 1326-1334, 2004.
24. Benedict C, Hallschmid M, Schmitz K, Schultes B, Ratter F, Fehm HL, Born J, Kern W. Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology 32: 239-243, 2007.
25. Benedict C, Kern W, Schultes B, Born J, Hallschmid M. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J Clin Endocrinol Metab 93: 1339-1344, 2008.
26. Benedict L, Nelson CA, Schunk E, Sullwold K, Seaquist ER. Effect of insulin on the brain activity obtained during visual and memory tasks in healthy human subjects. Neuroendocrinology 83: 20-26, 2006.
27. Benito-Leon J, Mitchell AJ, Hernandez-Gallego J, Bermejo-Pareja F. Obesity and impaired cognitive functioning in the elderly: a population-based cross-sectional study (NEDICES). Eur J Neurol 20: 899-906, 2013.
28. Berthoud HR. The neurobiology of food intake in an obesogenic environment. Proc Nutr Soc 1-10, 2012.
29. Bingham EM, Hopkins D, Smith D, Pernet A, Hallett W, Reed L, Marsden PK, Amiel SA. The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 51: 3384-3390, 2002.
30. Bischof GN, Park DC. Obesity and aging: consequences for cognition, brain structure, and brain function. Psychosom Med 77: 697-709, 2015.
31. Biswal BB, Mennes M, Zuo XN, Gohel S, Kelly C, Smith SM, Beckmann CF, Adelstein JS, Buckner RL, Colcombe S, Dogonowski AM, Ernst M, Fair D, Hampson M, Hoptman MJ, Hyde JS, Kiviniemi VJ, Kotter R, Li SJ, Lin CP, Lowe MJ, Mackay C, Madden DJ, Madsen KH, Margulies DS, Mayberg HS, McMahon K, Monk CS, Mostofsky SH, Nagel BJ, Pekar JJ, Peltier SJ, Petersen SE, Riedl V, Rombouts SA, Rypma B, Schlaggar BL, Schmidt S, Seidler RD, Siegle GJ, Sorg C, Teng GJ, Veijola J, Villringer A, Walter M, Wang L, Weng XC, Whitfield-Gabrieli S, Williamson P, Windischberger C, Zang YF, Zhang HY, Castellanos FX, Milham MP. Toward discovery science of human brain function. Proc Natl Acad Sci USA 107: 4734-4739, 2010.
32. Bjorgaas M, Sand T, Vik T, Jorde R. Quantitative EEG during controlled hypoglycaemia in diabetic and non-diabetic children. Diabet Med 15: 30-37, 1998.
33. Bohringer A, Schwabe L, Richter S, Schachinger H. Intranasal insulin attenuates the hypothalamic-pituitary-adrenal axis response to psychosocial stress. Psychoneuroendocrinology 33: 1394-1400, 2008.
34. Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, Ferreira ST, De Felice FG. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Abeta oligomers. J Clin Invest 122: 1339-1353, 2012.
35. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 44: 180-184, 1995.
36. Brange J, Volund A. Insulin analogs with improved pharmacokinetic profiles. Advanced Drug Delivery Rev 35: 307-335, 1999.
37. Brown LM, Clegg DJ, Benoit SC, Woods SC. Intraventricular insulin and leptin reduce food intake and body weight in C57BL/6J mice. Physiol Behav 89: 687- 691, 2006.
38. Brundel M, Kappelle LJ, Biessels GJ. Brain imaging in type 2 diabetes. Eur Neuropsychopharmacol 24: 1967-1981, 2014.
39. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, Kahn CR. Role of brain insulin receptor in control of body weight and reproduction. Science 289: 2122-2125, 2000.
40. Brunner YF, Benedict C, Freiherr J. Intranasal insulin reduces olfactory sensitivity in normosmic humans. J Clin Endocrinol Metab 98: E1626-1630, 2013.
41. Brunner YF, Kofoet A, Benedict C, Freiherr J. Central insulin administration improves odor-cued reactivation of spatial memory in young men. J Clin Endocrinol Metab 100: 212-219, 2015.
42. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain’s default network: anatomy, function, and relevance to disease. Ann NY Acad Sci 1124: 1-38, 2008.
43. Buzsaki G. Theta oscillations in the hippocampus. Neuron 33: 325-340, 2002.
44. Cagnin A, Gerhard A, Banati RB. In vivo imaging of neuroinflammation. Eur Neuropsychopharmacol 12: 581-586, 2002.
45. Card JP. Hypothalamus. In: Encyclopedia of Life Sciences. London: Nature Publishing Group, 2002.
46. Catalano PM, Presley L, Minium J, Hauguel-de Mouzon S. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care 32: 1076-1080, 2009.
47. Cazettes F, Cohen JI, Yau PL, Talbot H, Convit A. Obesity-mediated inflammation may damage the brain circuit that regulates food intake. Brain Res 1373: 101-109, 2011.
48. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med 359: 2558-2566, 2008.
49. Chan O, Sherwin RS. Hypothalamic regulation of glucose-stimulated insulin secretion. Diabetes 61: 564-565, 2012.
50. Cheah YS, Lee S, Ashoor G, Nathan Y, Reed LJ, Zelaya FO, Brammer MJ, Amiel SA. Ageing diminishes the modulation of human brain responses to visual food cues by meal ingestion. Int J Obes 38: 1186-1192, 2014.
51. Chechlacz M, Rotshtein P, Klamer S, Porubska K, Higgs S, Booth D, Fritsche A, Preissl H, Abele H, Birbaumer N, Nouwen A. Diabetes dietary management alters responses to food pictures in brain regions associated with motivation and emotion: a functional magnetic resonance imaging study. Diabetologia 52: 524-533, 2009.
52. Chen M, Woods SC, Porte D Jr. Effect of cerebral intraventricular insulin on pancreatic insulin secretion in the dog. Diabetes 24: 910-914, 1975.
53. Chen Y, Run X, Liang Z, Zhao Y, Dai CL, Iqbal K, Liu F, Gong CX. Intranasal insulin prevents anesthesia-induced hyperphosphorylation of tau in 3xTg-AD mice. Front Aging Neurosci 6: 100, 2014.
54. Chen YC, Jiao Y, Cui Y, Shang SA, Ding J, Feng Y, Song W, Ju SH, Teng GJ. Aberrant brain functional connectivity related to insulin resistance in type 2 diabetes: a restingstate fMRI study. Diabetes Care 37: 1689-1696, 2014.
55. Chiu SL, Chen CM, Cline HT. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron 58: 708-719, 2008.
56. Cholerton B, Baker LD, Craft S. Insulin, cognition, dementia. Eur J Pharmacol 719: 170-179, 2013.
57. Chuang YF, Tanaka T, Beason-Held LL, An Y, Terracciano A, Sutin AR, Kraut M, Singleton AB, Resnick SM, Thambisetty M. FTO genotype and aging: pleiotropic longitudinal effects on adiposity, brain function, impulsivity and diet. Mol Psychiatry 20: 133-139, 2015.
58. Chung CC, Pimentel D, Jor’dan AJ, Hao Y, Milberg W, Novak V. Inflammation associated declines in cerebral vasoreactivity and cognition in type 2 diabetes. Neurology 85: 450-458, 2015.
59. Claussnitzer M, Dankel SN, Kim KH, Quon G, Meuleman W, Haugen C, Glunk V, Sousa IS, Beaudry JL, Puviindran V, Abdennur NA, Liu J, Svensson PA, Hsu YH, Drucker DJ, Mellgren G, Hui CC, Hauner H, Kellis M. FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 373: 895-907, 2015.
60. Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S. Long acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer’s disease dementia. J Alzheimers Dis 45: 1269-1270, 2015.
61. Claxton A, Baker LD, Wilkinson CW, Trittschuh EH, Chapman D, Watson GS, Cholerton B, Plymate SR, Arbuckle M, Craft S. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer’s disease. J Alzheimers Dis 35: 789-797, 2013.
62. Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 55: 978-987, 2006.
63. Clegg DJ, Riedy CA, Smith KA, Benoit SC, Woods SC. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes 52: 682-687, 2003.
64. Coenen VA, Panksepp J, Hurwitz TA, Urbach H, Madler B. Human medial forebrain bundle (MFB) and anterior thalamic radiation (ATR): imaging of two major subcortical pathways and the dynamic balance of opposite affects in understanding depression. J Neuropsychiatry Clin Neurosci 24: 223-236, 2012.
65. Cohen AD, Klunk WE. Early detection of Alzheimer’s disease using PiB and FDG PET. Neurobiol Dis 72: 117-122, 2014.
66. Comings DE, Muhleman D, Ahn C, Gysin R, Flanagan SD. The dopamine D2 receptor gene: a genetic risk factor in substance abuse. Drug Alcohol Depend 34: 175-180, 1994.
67. Convit A, Wolf OT, Tarshish C, de Leon MJ. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci USA 100: 2019-2022, 2003.
68. Cook DG, Leverenz JB, McMillan PJ, Kulstad JJ, Ericksen S, Roth RA, Schellenberg GD, Jin LW, Kovacina KS, Craft S. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer’s disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol 162: 313-319, 2003.
69. Coomans CP, Biermasz NR, Geerling JJ, Guigas B, Rensen PC, Havekes LM, Romijn JA. Stimulatory effect of insulin on glucose uptake by muscle involves the central nervous system in insulin-sensitive mice. Diabetes 60: 3132-3140, 2011.
70. Coomans CP, Geerling JJ, Guigas B, van den Hoek AM, Parlevliet ET, Ouwens DM, Pijl H, Voshol PJ, Rensen PC, Havekes LM, Romijn JA. Circulating insulin stimulates fatty acid retention in white adipose tissue via KATP channel activation in the central nervous system only in insulin-sensitive mice. J Lipid Res 52: 1712-1722, 2011.
71. Cornelis MC, Rimm EB, Curhan GC, Kraft P, Hunter DJ, Hu FB, van Dam RM. Obesity susceptibility loci and uncontrolled eating, emotional eating and cognitive restraint behaviors in men and women. Obesity 22: 135-141, 2014.
72. Corp ES, Woods SC, Porte D Jr, Dorsa DM, Figlewicz DP, Baskin DG. Localization of 125I-insulin binding sites in the rat hypothalamus by quantitative autoradiography. Neurosci Lett 70: 17-22, 1986.
73. Craft S. Insulin resistance syndrome and Alzheimer’s disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging 26 Suppl 1: 65-69, 2005.
74. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B. Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment: A Pilot Clinical Trial. Arch Neurol 69: 29-38, 2012.
75. Craft S, Newcomer J, Kanne S, Dagogo-Jack S, Cryer P, Sheline Y, Luby J, Dagogo-Jack A, Alderson A. Memory improvement following induced hyperinsulinemia in Alzheimer’s disease. Neurobiol Aging 17: 123-130, 1996.
76. Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D Jr. Cerebrospinal fluid and plasma insulin levels in Alzheimer’s disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50: 164-168, 1998.
77. Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, Roumain J, Bennett PH, Knowler WC. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes 49: 2208-2211, 2000.
78. Dash S, Xiao C, Morgantini C, Koulajian K, Lewis GF. Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations. Diabetes 64: 766-774, 2015.
79. Dash S, Xiao C, Morgantini C, Koulajian K, Lewis GF. Is insulin action in the brain relevant in regulating blood glucose in humans? J Clin Endocrinol Metab 100: 2525-2531, 2015.
80. Davis SN, Dunham B, Walmsley K, Shavers C, Neal D, Williams P, Cherrington AD. Brain of the conscious dog is sensitive to physiological changes in circulating insulin. Am J Physiol Endocrinol Metab 272: E567-E575, 1997.
81. De Felice FG. Alzheimer’s disease and insulin resistance: translating basic science into clinical applications. J Clin Invest 123: 531-539, 2013.
82. De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP, Viola KL, Zhao WQ, Ferreira ST, Klein WL. Protection of synapses against Alzheimer’s-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci USA 106: 1971-1976, 2009.
83. De Feo P, Perriello G, Ventura MM, Brunetti P, Santeusanio F, Gerich JE, Bolli GB. The pancreatic-adrenocortical-pituitary clamp technique for study of counterregulation in humans. Am J Physiol Endocrinol Metab 252: E565-E570, 1987.
84. De Silva A, Salem V, Matthews PM, Dhillo WS. The use of functional MRI to study appetite control in the CNS. Exp Diabetes Res 2012: 764017, 2012.
85. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E214-E223, 1979.
86. Del Parigi A, Gautier JF, Chen K, Salbe AD, Ravussin E, Reiman E, Tataranni PA. Neuroimaging and obesity: mapping the brain responses to hunger and satiation in humans using positron emission tomography. Ann NY Acad Sci 967: 389-397, 2002.
87. Del Parigi A, Chen K, Salbe AD, Hill JO, Wing RR, Reiman EM, Tataranni PA. Successful dieters have increased neural activity in cortical areas involved in the control of behavior. Int J Obes 31: 440-448, 2007.
88. Den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A, Breteler MM. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46: 1604-1610, 2003.
89. Dennis EL, Jahanshad N, Braskie MN, Warstadt NM, Hibar DP, Kohannim O, Nir TM, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Toga AW, Wright MJ, Thompson PM. Obesity gene NEGR1 associated with white matter integrity in healthy young adults. Neuroimage 102: 548-557, 2014.
90. Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci 8: 585-589, 2005.
91. Diabetes IDFI. International Diabetes Federation (7 ed.). Brussels, Belgium: IDFI, 2015.
92. Diekelmann S, Born J. The memory function of sleep. Nat Rev Neurosci 11: 114-126, 2010.
93. Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P, Carlsson LM, Kiess W, Vatin V, Lecoeur C, Delplanque J, Vaillant E, Pattou F, Ruiz J, Weill J, Levy-Marchal C, Horber F, Potoczna N, Hercberg S, Le Stunff C, Bougneres P, Kovacs P, Marre M, Balkau B, Cauchi S, Chevre JC, Froguel P. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39: 724-726, 2007.
94. Dorfman MD, Thaler JP. Hypothalamic inflammation and gliosis in obesity. Curr Opin Endocrinol Diabetes Obes 22: 325-330, 2015.
95. Doyle P, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B. Four-day hyperinsulinemia in euglycemic conditions alters local cerebral glucose utilization in specific brain nuclei of freely moving rats. Brain Res 684: 47-55, 1995.
96. Duning T, van den Heuvel I, Dickmann A, Volkert T, Wempe C, Reinholz J, Lohmann H, Freise H, Ellger B. Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction. Diabetes Care 33: 639-644, 2010.
97. Edgerton DS, Cherrington AD. Is brain insulin action relevant to the control of plasma glucose in humans? Diabetes 64: 696-699, 2015.
98. Egefjord L, Gejl M, Moller A, Braendgaard H, Gottrup H, Antropova O, Moller N, Poulsen HE, Gjedde A, Brock B, Rungby J. Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer s disease: protocol for a controlled, randomized double-blinded trial. Danish Med J 59: A4519, 2012.
99. Engel AK, Fries P. Beta-band oscillations-signalling the status quo? Curr Opin Neurobiol 20: 156-165, 2010.
100. Enoksson S, Degerman E, Hagstrom-Toft E, Large V, Arner P. Various phosphodiesterase subtypes mediate the in vivo antilipolytic effect of insulin on adipose tissue and skeletal muscle in man. Diabetologia 41: 560-568, 1998.
101. Fanelli CG, Dence CS, Markham J, Videen TO, Paramore DS, Cryer PE, Powers WJ. Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes 47: 1444-1450, 1998.
102. Feld GB, Wilhem I, Benedict C, Rudel B, Klameth C, Born J, Hallschmid M. Central nervous insulin signaling in sleep-associated memory formation and neuroendocrine regulation. Neuropsychopharmacology 41: 1540-1550, 2016.
103. Feldman DE. Synaptic mechanisms for plasticity in neocortex. Annu Rev Neurosci 32: 33-55, 2009.
104. Felsted JA, Ren X, Chouinard-Decorte F, Small DM. Genetically determined differences in brain response to a primary food reward. J Neurosci 30: 2428-2432, 2010.
105. Ferreira ST, Clarke JR, Bomfim TR, De Felice FG. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer’s disease. Alzheimers Dement 10: S76-S83, 2014.
106. Fields RD, Stevens-Graham B. New insights into neuron-glia communication. Science 298: 556-562, 2002.
107. Figlewicz DP, Sipols AJ. Energy regulatory signals and food reward. Pharmacol Biochem Behav 97: 15-24, 2010.
108. Figlewicz DP, Szot P, Chavez M, Woods SC, Veith RC. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res 644: 331-334, 1994.
109. Filippi BM, Yang CS, Tang C, Lam TK. Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell Metab 16: 500-510, 2012.
110. Fishel MA, Watson GS, Montine TJ, Wang Q, Green PS, Kulstad JJ, Cook DG, Peskind ER, Baker LD, Goldgaber D, Nie W, Asthana S, Plymate SR, Schwartz MW, Craft S. Hyperinsulinemia provokes synchronous increases in central inflammation and betaamyloid in normal adults. Arch Neurol 62: 1539-1544, 2005.
111. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303: 235-241, 2010.
112. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 293: 1861-1867, 2005.
113. Foster LA, Ames NK, Emery RS. Food intake and serum insulin responses to intraventricular infusions of insulin and IGF-I. Physiol Behav 50: 745-749, 1991.
114. Frank S, Kullmann S, Veit R. Food related processes in the insular cortex. Front Hum Neurosci 7: 499, 2013.
115. Frank S, Laharnar N, Kullmann S, Veit R, Canova C, Hegner YL, Fritsche A, Preissl H. Processing of food pictures: influence of hunger, gender and calorie content. Brain Res 1350: 159-166, 2010.
116. Frank S, Wilms B, Veit R, Ernst B, Thurnheer M, Kullmann S, Fritsche A, Birbaumer N, Preissl H, Schultes B. Altered brain activity in severely obese women may recover after Roux-en Y gastric bypass surgery. Int J Obes 38: 341-348, 2014.
117. Franke K, Harder T, Aerts L, Melchior K, Fahrenkrog S, Rodekamp E, Ziska T, Van Assche FA, Dudenhausen JW, Plagemann A. "Programming" of orexigenic and anorexigenic hypothalamic neurons in offspring of treated and untreated diabetic mother rats. Brain Res 1031: 276-283, 2005.
118. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CN, Doney AS, Morris AD, Smith GD, Hattersley AT, McCarthy MI. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316: 889-894, 2007.
119. Fredriksson R, Hagglund M, Olszewski PK, Stephansson O, Jacobsson JA, Olszewska AM, Levine AS, Lindblom J, Schioth HB. The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology 149: 2062-2071, 2008.
120. Freiherr J, Hallschmid M, Frey WH, 2nd Brunner YF, Chapman CD, Holscher C, Craft S, De Felice FG, Benedict C. Intranasal insulin as a treatment for Alzheimer’s disease: a review of basic research and clinical evidence. CNS Drugs 27: 505-514, 2013.
121. Frier BM, Russell-Jones D, Heise T. A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review. Diabetes Obes Metab 15: 978-986, 2013.
122. Fritsche A, Häring H. At last, a weight neutral insulin? Int J Obes Relat Metab Disord 28 Suppl 2: S41-S46, 2004.
123. Frolich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Turk A, Hoyer S, Zochling R, Boissl KW, Jellinger K, Riederer P. Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease. J Neural Transm 105: 423-438, 1998.
124. Fuster JM. The prefrontal cortex-an update: time is of the essence. Neuron 30: 319-333, 2001.
125. Gancheva S, Koliaki C, Bierwagen A, Nowotny P, Heni M, Fritsche A, Häring HU, Szendroedi J, Roden M. Effects of intranasal insulin on hepatic fat accumulation and energy metabolism in humans. Diabetes 64: 1966-1975, 2015.
126. Gasparini L, Gouras GK, Wang R, Gross RS, Beal MF, Greengard P, Xu H. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal betaamyloid and requires mitogen-activated protein kinase signaling. J Neurosci 21: 2561-2570, 2001.
127. Gautier JF, Chen K, Salbe AD, Bandy D, Pratley RE, Heiman M, Ravussin E, Reiman EM, Tataranni PA. Differential brain responses to satiation in obese and lean men. Diabetes 49: 838-846, 2000.
128. Gerozissis K. Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol 23: 1-25, 2003.
129. Girard J. Insulin’s effect on the liver: "direct or indirect?" continues to be the question. J Clin Invest 116: 302-304, 2006.
130. Goldman RL, Canterberry M, Borckardt JJ, Madan A, Byrne TK, George MS, O’Neil PM, Hanlon CA. Executive control circuitry differentiates degree of success in weight loss following gastric-bypass surgery. Obesity 21: 2189-2196, 2013.
131. Gomez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 9: 568-578, 2008.
132. Gottschalk A, Ellger B. Whenever you lose connection, take intranasal insulin? Diabetes 64: 687-688, 2015.
133. Gray SM, Meijer RI, Barrett EJ. Insulin regulates brain function, but how does it get there? Diabetes 63: 3992-3997, 2014.
134. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, Cummings SR. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160: 174-180, 2000.
135. Grillo CA, Piroli GG, Kaigler KF, Wilson SP, Wilson MA, Reagan LP. Downregulation of hypothalamic insulin receptor expression elicits depressive-like behaviors in rats. Behav Brain Res 222: 230-235, 2011.
136. Group HSCR, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358: 1991-2002, 2008.
137. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and metaanalysis. BMC Public Health 9: 88, 2009.
138. Gunstad J, Paul RH, Cohen RA, Tate DF, Spitznagel MB, Gordon E. Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Comp Psychiatry 48: 57-61, 2007.
139. Gupta A, Srinivasan M, Thamadilok S, Patel MS. Hypothalamic alterations in fetuses of high fat diet-fed obese female rats. J Endocrinol 200: 293-300, 2009.
140. Guthoff M, Grichisch Y, Canova C, Tschritter O, Veit R, Hallschmid M, Häring HU, Preissl H, Hennige AM, Fritsche A. Insulin modulates food-related activity in the central nervous system. J Clin Endocrinol Metab 95: 748-755, 2010.
141. Guthoff M, Stingl KT, Tschritter O, Rogic M, Heni M, Stingl K, Hallschmid M, Häring HU, Fritsche A, Preissl H, Hennige AM. The insulin-mediated modulation of visually evoked magnetic fields is reduced in obese subjects. PLoS One 6: e19482, 2011.
142. Haber SN. Neuroanatomy of reward: a view from the ventral striatum. In: Neurobiology of Sensation and Reward, edited by Gottfried JA. Boca Raton, FL: CRC, 2011.
143. Hallschmid M, Benedict C, Schultes B, Born J, Kern W. Obese men respond to cognitive but not to catabolic brain insulin signaling. Int J Obes 32: 275-282, 2008.
144. Hallschmid M, Benedict C, Schultes B, Fehm HL, Born J, Kern W. Intranasal insulin reduces body fat in men but not in women. Diabetes 53: 3024-3029, 2004.
145. Hallschmid M, Higgs S, Thienel M, Ott V, Lehnert H. Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women. Diabetes 61: 782-789, 2012.
146. Hallschmid M, Jauch-Chara K, Korn O, Molle M, Rasch B, Born J, Schultes B, Kern W. Euglycemic infusion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects. Diabetes 59: 1101-1107, 2010.
147. Hallschmid M, Schultes B, Marshall L, Molle M, Kern W, Bredthauer J, Fehm HL, Born J. Transcortical direct current potential shift reflects immediate signaling of systemic insulin to the human brain. Diabetes 53: 2202-2208, 2004.
148. Hallschmid M, Smolnik R, McGregor G, Born J, Fehm HL. Overweight humans are resistant to the weight-reducing effects of melanocortin4-10. J Clin Endocrinol Metab 91: 522-525, 2006.
149. Hansen HH, Fabricius K, Barkholt P, Niehoff ML, Morley JE, Jelsing J, Pyke C, Bjerre Knudsen L, Farr SA, Vrang N. The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence accelerated mouse model of Alzheimer’s disease. J Alzheimers Dis 46: 877-888, 2015.
150. Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol Sci 12: 383-388, 1991.
151. Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science 256: 184-185, 1992.
152. Hare TA, Camerer CF, Rangel A. Self-control in decision-making involves modulation of the vmPFC valuation system. Science 324: 646-648, 2009.
153. Hasselbalch SG, Knudsen GM, Videbaek C, Pinborg LH, Schmidt JF, Holm S, Paulson OB. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes 48: 1915-1921, 1999.
154. Hasselmo ME. What is the function of hippocampal theta rhythm? Linking behavioral data to phasic properties of field potential and unit recording data. Hippocampus 15: 936-949, 2005.
155. Hassing LB, Grant MD, Hofer SM, Pedersen NL, Nilsson SE, Berg S, McClearn G, Johansson B. Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study. J Int Neuropsychol Soc 10: 599-607, 2004.
156. Haupt A, Thamer C, Staiger H, Tschritter O, Kirchhoff K, Machicao F, Häring HU, Stefan N, Fritsche A. Variation in the FTO gene influences food intake but not energy expenditure. Exp Clin Endocrinol Diabetes 117: 194-197, 2009.
157. Havrankova J, Brownstein M, Roth J. Insulin and insulin receptors in rodent brain. Diabetologia 20 Suppl: 268-273, 1981.
158. Havrankova J, Roth J, Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272: 827-829, 1978.
159. Havrankova J, Roth J, Brownstein MJ. Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin- treated rodents. J Clin Invest 64: 636-642, 1979.
160. Hege MA, Stingl KT, Ketterer C, Häring HU, Heni M, Fritsche A, Preissl H. Working memory-related brain activity is associated with outcome of lifestyle intervention. Obesity 21: 2488-2494, 2013.
161. Heni M, Hennige AM, Peter A, Siegel-Axel D, Ordelheide AM, Krebs N, Machicao F, Fritsche A, Häring HU, Staiger H. Insulin promotes glycogen storage and cell proliferation in primary human astrocytes. PLoS One 6: e21594, 2011.
162. Heni M, Kullmann S, Fritsche A. Comment on: Teeuwisse et al. Short-term caloric restriction normalizes hypothalamic neuronal responsiveness to glucose ingestion in patients with type 2 diabetes Diabetes 2012;61: 3255-3259. Diabetes 62: e5, 2013.
163. Heni M, Kullmann S, Gallwitz B, Häring HU, Preissl H, Fritsche A. Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans. Mol Metab 4: 971-976, 2015.
164. Heni M, Kullmann S, Ketterer C, Guthoff M, Bayer M, Staiger H, Machicao F, Häring HU, Preissl H, Veit R, Fritsche A. Differential effect of glucose ingestion on the neural processing of food stimuli in lean and overweight adults. Hum Brain Mapp 35: 918-928, 2013.
165. Heni M, Kullmann S, Ketterer C, Guthoff M, Linder K, Wagner R, Stingl KT, Veit R, Staiger H, Häring HU, Preissl H, Fritsche A. Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions. Diabetologia 55: 1773-1782, 2012.
166. Heni M, Kullmann S, Preissl H, Fritsche A, Häring HU. Impaired insulin action in the human brain: causes and metabolic consequences. Nat Rev Endocrinol 11: 701-711, 2015.
167. Heni M, Kullmann S, Veit R, Ketterer C, Frank S, Machicao F, Staiger H, Häring HU, Preissl H, Fritsche A. Variation in the obesity risk gene FTO determines the postprandial cerebral processing of food stimuli in the prefrontal cortex. Mol Metab 3: 109-113, 2014.
168. Heni M, Kullmann S, Wagner R, Machicao F, Staiger H, Bruning JC, Häring HU, Small DM, Preissl H, Fritsche A. Evidence for interaction between the obesity-risk gene FTO and dopamine D2 receptor gene ANKK1/TaqIA. Diabetes Supplement 64: A42, 2015.
169. Heni M, Schopfer P, Peter A, Sartorius T, Fritsche A, Synofzik M, Häring HU, Maetzler W, Hennige AM. Evidence for altered transport of insulin across the blood-brain barrier in insulin-resistant humans. Acta Diabetol 51: 679-681, 2013.
170. Heni M, Wagner R, Kullmann S, Preissl H, Fritsche A. Response to Comment on Heni et al. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes 2014;63: 4083-4088. Diabetes 64: e8-e9, 2015.
171. Heni M, Wagner R, Kullmann S, Veit R, Mat Husin H, Linder K, Benkendorff C, Peter A, Stefan N, Häring HU, Preissl H, Fritsche A. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes 63: 4083-4088, 2014.
172. Hennige AM, Sartorius T, Lutz SZ, Tschritter O, Preissl H, Hopp S, Fritsche A, Rammensee HG, Ruth P, Häring HU. Insulin-mediated cortical activity in the slow frequency range is diminished in obese mice and promotes physical inactivity. Diabetologia 52: 2416-2424, 2009.
173. Hennige AM, Sartorius T, Tschritter O, Preissl H, Fritsche A, Ruth P, Häring HU. Tissue selectivity of insulin detemir action in vivo. Diabetologia 49: 1274-1282, 2006.
174. Herman MA, Rosen ED. Making biological sense of GWAS data: lessons from the FTO locus. Cell Metab 22: 538-539, 2015.
175. Hess ME, Hess S, Meyer KD, Verhagen LA, Koch L, Bronneke HS, Dietrich MO, Jordan SD, Saletore Y, Elemento O, Belgardt BF, Franz T, Horvath TL, Ruther U, Jaffrey SR, Kloppenburg P, Bruning JC. The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nat Neurosci 16: 1042-1048, 2013.
176. Hill JM, Lesniak MA, Pert CB, Roth J. Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience 17: 1127-1138, 1986.
177. Ho AJ, Stein JL, Hua X, Lee S, Hibar DP, Leow AD, Dinov ID, Toga AW, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, DeCarli CS, DeChairo BM, Potkin SG, Jack CR Jr, Weiner MW, Raji CA, Lopez OL, Becker JT, Carmichael OT, Thompson PM. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci USA 107: 8404-8409, 2010.
178. Holst M, Eswaran H, Lowery C, Murphy P, Norton J, Preissl H. Development of auditory evoked fields in human fetuses and newborns: a longitudinal MEG study. Clin Neurophysiol 116: 1949-1955, 2005.
179. Honda K, Kamisoyama H, Saneyasu T, Sugahara K, Hasegawa S. Central administration of insulin suppresses food intake in chicks. Neurosci Lett 423: 153-157, 2007.
180. Hong M, Lee VM. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272: 19547-19553, 1997.
181. Hoogenboom WS, Marder TJ, Flores VL, Huisman S, Eaton HP, Schneiderman JS, Bolo NR, Simonson DC, Jacobson AM, Kubicki M, Shenton ME, Musen G. Cerebral white matter integrity and resting-state functional connectivity in middle-aged patients with type 2 diabetes. Diabetes 63: 728-738, 2014.
182. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409-2415, 1995.
183. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1- mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271: 665-668, 1996.
184. Huang CC, Lee CC, Hsu KS. The role of insulin receptor signaling in synaptic plasticity and cognitive function. Chang Gung Med J 33: 115-125, 2010.
185. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. "Sniffin’ sticks": olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 22: 39-52, 1997.
186. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131-141, 1997.
187. Ikeda H, West DB, Pustek JJ, Figlewicz DP, Greenwood MR, Porte D Jr, Woods SC. Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite 7: 381-386, 1986.
188. Irvine EE, Drinkwater L, Radwanska K, Al-Qassab H, Smith MA, O’Brien M, Kielar C, Choudhury AI, Krauss S, Cooper JD, Withers DJ, Giese KP. Insulin receptor substrate 2 is a negative regulator of memory formation. Learn Mem 18: 375-383, 2011.
189. Ishibashi K, Kawasaki K, Ishiwata K, Ishii K. Reduced uptake of (18)F-FDG and (15)OH2O in Alzheimer’s disease-related regions after glucose loading. J Cereb Blood Flow Metab 35: 1380-1385, 2015.
190. Iwen KA, Scherer T, Heni M, Sayk F, Wellnitz T, Machleidt F, Preissl H, Häring HU, Fritsche A, Lehnert H, Buettner C, Hallschmid M. Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans. J Clin Endocrinol Metab 99: E246-E251, 2014.
191. Jauch-Chara K, Friedrich A, Rezmer M, Melchert UH, HGSE, Hallschmid M, Oltmanns KM. Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans. Diabetes 61: 2261-2268, 2012.
192. Jensen MD, Caruso M, Heiling V, Miles JM. Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 38: 1595-1601, 1989.
193. Jessen L, Clegg DJ, Bouman SD. Evaluation of the lack of anorectic effect of intracerebro-ventricular insulin in rats. Am J Physiol Regul Integr Comp Physiol 298: R43-R50, 2010.
194. Jonsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P, Sedvall GC. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4: 290-296, 1999.
195. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164: 1327-1333, 2004.
196. Kang S, Creagh FM, Peters JR, Brange J, Volund A, Owens DR. Comparison of subcutaneous soluble human insulin and insulin analogs (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects. Diabetes Care 14: 571-577, 1991.
197. Karczewska-Kupczewska M, Tarasow E, Nikolajuk A, Stefanowicz M, Matulewicz N, Otziomek E, Gorska M, Straczkowski M, Kowalska I. The effect of insulin infusion on the metabolites in cerebral tissues assessed with proton magnetic resonance spectroscopy in young healthy subjects with high and low insulin sensitivity. Diabetes Care 36: 2787-2793, 2013.
198. Karra E, O’Daly OG, Choudhury AI, Yousseif A, Millership S, Neary MT, Scott WR, Chandarana K, Manning S, Hess ME, Iwakura H, Akamizu T, Millet Q, Gelegen C, Drew ME, Rahman S, Emmanuel JJ, Williams SC, Ruther UU, Bruning JC, Withers DJ, Zelaya FO, Batterham RL. A link between FTO, ghrelin, and impaired brain food-cue responsivity. J Clin Invest 123: 3539-3551, 2013.
199. Kern W, Benedict C, Schultes B, Plohr F, Moser A, Born J, Fehm HL, Hallschmid M. Low cerebrospinal fluid insulin levels in obese humans. Diabetologia 49: 2790-2792, 2006.
200. Kern W, Born J, Schreiber H, Fehm HL. Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes 48: 557-563, 1999.
201. Kern W, Peters A, Born J, Fehm HL, Schultes B. Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia. Metabolism 54: 391-396, 2005.
202. Kern W, Peters A, Fruehwald-Schultes B, Deininger E, Born J, Fehm HL. Improving influence of insulin on cognitive functions in humans. Neuroendocrinology 74: 270-280, 2001.
203. Ketterer C, Heni M, Stingl K, Tschritter O, Linder K, Wagner R, Machicao F, Häring HU, Preissl H, Staiger H, Fritsche A. Polymorphism rs3123554 in CNR2 reveals gender-specific effects on body weight and affects loss of body weight and cerebral insulin action. Obesity 22: 925-931, 2014.
204. Ketterer C, Heni M, Thamer C, Herzberg-Schafer SA, Häring HU, Fritsche A. Acute, short-term hyperinsulinemia increases olfactory threshold in healthy subjects. Int J Obes 35: 1135-1138, 2011.
205. Killgore WD, Yurgelun-Todd DA. Positive affect modulates activity in the visual cortex to images of high calorie foods. Int J Neurosci 117: 643-653, 2007.
206. Killick R, Scales G, Leroy K, Causevic M, Hooper C, Irvine EE, Choudhury AI, Drinkwater L, Kerr F, Al-Qassab H, Stephenson J, Yilmaz Z, Giese KP, Brion JP, Withers DJ, Lovestone S. Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice. Biochem Biophys Res Commun 386: 257-262, 2009.
207. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25: 1862-1868, 2002.
208. King GL, Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science 227: 1583-1586, 1985.
209. Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, Andres R, Saudek C, Edelstein SL, Arakaki R, Murphy MB, Shamoon H, Diabetes Prevention Program Research. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes 54: 2404-2414, 2005.
210. Kleinridders A, Ferris HA, Cai W, Kahn CR. Insulin action in brain regulates systemic metabolism and brain function. Diabetes 63: 2232-2243, 2014.
211. Koch L, Wunderlich FT, Seibler J, Konner AC, Hampel B, Irlenbusch S, Brabant G, Kahn CR, Schwenk F, Bruning JC. Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest 118: 2132-2147, 2008.
212. Koekkoek PS, Rutten GE, Biessels GJ. Cognitive disorders in diabetic patients. Handb Clin Neurol 126: 145-166, 2014.
213. Kroemer NB, Krebs L, Kobiella A, Grimm O, Vollstadt-Klein S, Wolfensteller U, Kling R, Bidlingmaier M, Zimmermann US, Smolka MN. (Still) longing for food: insulin reactivity modulates response to food pictures. Hum Brain Mapp 34: 2367-2380, 2013.
214. Krug R, Benedict C, Born J, Hallschmid M. Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory. J Clin Endocrinol Metab 95: E468-E472, 2010.
215. Kuhn AB, Feis DL, Schilbach L, Kracht L, Hess ME, Mauer J, Bruning JC, Tittgemeyer M. FTO gene variant modulates the neural correlates of visual food perception. Neuroimage 128: 21-31, 2016.
216. Kullmann S, Frank S, Heni M, Ketterer C, Veit R, Häring HU, Fritsche A, Preissl H. Intranasal insulin modulates intrinsic reward and prefrontal circuitry of the human brain in lean women. Neuroendocrinology 97: 176-182, 2013.
217. Kullmann S, Heni M, Fritsche A, Preissl H. Insulin action in the human brain: evidence from neuroimaging studies. J Neuroendocrinol 27: 419-423, 2015.
218. Kullmann S, Heni M, Linder K, Zipfel S, Häring HU, Veit R, Fritsche A, Preissl H. Resting-state functional connectivity of the human hypothalamus. Hum Brain Mapp 35: 6088-6096, 2014.
219. Kullmann S, Heni M, Veit R, Ketterer C, Schick F, Häring HU, Fritsche A, Preissl H. The obese brain: association of body mass index and insulin sensitivity with resting state network functional connectivity. Hum Brain Mapp 33: 1052-1061, 2012.
220. Kullmann S, Heni M, Veit R, Scheffler K, Machann J, Häring HU, Fritsche A, Preissl H. Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults. Diabetes Care 38: 1044-1050, 2015.
221. Kullmann S, Pape AA, Heni M, Ketterer C, Schick F, Häring HU, Fritsche A, Preissl H, Veit R. Functional network connectivity underlying food processing: disturbed salience and visual processing in overweight and obese adults. Cereb Cortex 23: 1247-1256, 2013.
222. Kullmann S, Schweizer F, Veit R, Fritsche A, Preissl H. Compromised white matter integrity in obesity. Obes Rev 16: 273-281, 2015.
223. Lee CC, Kuo YM, Huang CC, Hsu KS. Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation. Neurobiol Aging 30: 377-387, 2009.
224. Lee YH, White MF. Insulin receptor substrate proteins and diabetes. Arch Pharmacol Res 27: 361-370, 2004.
225. Li L, Holscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 56: 384-402, 2007.
226. Lin HV, Plum L, Ono H, Gutierrez-Juarez R, Shanabrough M, Borok E, Horvath TL, Rossetti L, Accili D. Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes 59: 337-346, 2010.
227. Lin X, Taguchi A, Park S, Kushner JA, Li F, Li Y, White MF. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 114: 908-916, 2004.
228. Linder K, Schleger F, Ketterer C, Fritsche L, Kiefer-Schmidt I, Hennige A, Häring HU, Preissl H, Fritsche A. Maternal insulin sensitivity is associated with oral glucose-induced changes in fetal brain activity. Diabetologia 57: 1192-1198, 2014.
229. Linder K, Schleger F, Kiefer-Schmidt I, Fritsche L, Kummel S, Heni M, Weiss M, Häring HU, Preissl H, Fritsche A. Gestational diabetes impairs human fetal postprandial brain activity. J Clin Endocrinol Metab 100: 4029-4036, 2015.
230. Marks DR, Tucker K, Cavallin MA, Mast TG, Fadool DA. Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors. J Neurosci 29: 6734-6751, 2009.
231. Marty N, Dallaporta M, Thorens B. Brain glucose sensing, counterregulation, and energy homeostasis. Physiology 22: 241-251, 2007.
232. Matsuda M, Liu Y, Mahankali S, Pu Y, Mahankali A, Wang J, DeFronzo RA, Fox PT, Gao JH. Altered hypothalamic function in response to glucose ingestion in obese humans. Diabetes 48: 1801-1806, 1999.
233. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
234. McAllister E, Pacheco-Lopez G, Woods SC, Langhans W. Inconsistencies in the hypophagic action of intracerebroventricular insulin in mice. Physiol Behav 151: 623-628, 2015.
235. McCaffery JM, Haley AP, Sweet LH, Phelan S, Raynor HA, Del Parigi A, Cohen R, Wing RR. Differential functional magnetic resonance imaging response to food pictures in successful weight-loss maintainers relative to normal-weight and obese controls. Am J Clin Nutr 90: 928-934, 2009.
236. McConathy J, Sheline YI. Imaging biomarkers associated with cognitive decline: a review. Biol Psychiatry 77: 685-692, 2015.
237. McFarlane SI. Insulin therapy and type 2 diabetes: management of weight gain. J Clin Hypertens 11: 601-607, 2009.
238. McGowan MK, Andrews KM, Grossman SP. Chronic intrahypothalamic infusions of insulin or insulin antibodies alter body weight and food intake in the rat. Physiol Behav 51: 753-766, 1992.
239. Mehran AE, Templeman NM, Brigidi GS, Lim GE, Chu KY, Hu X, Botezelli JD, Asadi A, Hoffman BG, Kieffer TJ, Bamji SX, Clee SM, Johnson JD. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab 16: 723-737, 2012.
240. Miller EK. The prefrontal cortex: complex neural properties for complex behavior. Neuron 22: 15-17, 1999.
241. Moheet A, Emir UE, Terpstra M, Kumar A, Eberly LE, Seaquist ER, Oz G. Initial experience with seven tesla magnetic resonance spectroscopy of hypothalamic GABA during hyperinsulinemic euglycemia and hypoglycemia in healthy humans. Magn Reson Med 71: 12-18, 2014.
242. Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci 1353: 60-71, 2015.
243. Molnar G, Farago N, Kocsis AK, Rozsa M, Lovas S, Boldog E, Baldi R, Csajbok E, Gardi J, Puskas LG, Tamas G. GABAergic neurogliaform cells represent local sources of insulin in the cerebral cortex. J Neurosci 34: 1133-1137, 2014.
244. Moloney AM, Griffin RJ, Timmons S, O’Connor R, Ravid R, O’Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer’s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 31: 224-243, 2010.
245. Moran C, Beare R, Phan TG, Bruce DG, Callisaya ML, Srikanth V, Alzheimer’s Disease Neuroimaging Initiative. Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology 85: 1123-1130, 2015.
246. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 443: 289-295, 2006.
247. Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, Tsui W, Ginestroni A, Bessi V, Fayyazz M, Caffarra P, Pupi A. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer’s disease. J Nucl Med 47: 1778-1786, 2006.
248. Moult PR, Harvey J. Hormonal regulation of hippocampal dendritic morphology and synaptic plasticity. Cell Adhesion Migration 2: 269-275, 2008.
249. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8: 1298-1308, 1994.
250. Muller TD, Tschop MH, Hofmann S. Emerging function of fat mass and obesityassociated protein (fto). PLoS Genet 9: e1003223, 2013.
251. Muntzel MS, Anderson EA, Johnson AK, Mark AL. Mechanisms of insulin action on sympathetic nerve activity. Clin Exp Hypertens 17: 39-50, 1995.
252. Musen G, Jacobson AM, Bolo NR, Simonson DC, Shenton ME, McCartney RL, Flores VL, Hoogenboom WS. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes 61: 2375-2379, 2012.
253. Nagaraja TN, Patel P, Gorski M, Gorevic PD, Patlak CS, Fenstermacher JD. In normal rat, intraventricularly administered insulin-like growth factor-1 is rapidly cleared from CSF with limited distribution into brain. Cerebrospinal Fluid Res 2: 5, 2005.
254. Nooyens AC, Baan CA, Spijkerman AM, Verschuren WM. Type 2 diabetes and cognitive decline in middle-aged men and women: the Doetinchem Cohort Study. Diabetes Care 33: 1964-1969, 2010.
255. Novak V, Last D, Alsop DC, Abduljalil AM, Hu K, Lepicovsky L, Cavallerano J, Lipsitz LA. Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care 29: 1529-1534, 2006.
256. Novak V, Milberg W, Hao Y, Munshi M, Novak P, Galica A, Manor B, Roberson P, Craft S, Abduljalil A. Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Diabetes Care 37: 751-759, 2014.
257. Nummenmaa L, Hirvonen J, Hannukainen JC, Immonen H, Lindroos MM, Salminen P, Nuutila P. Dorsal striatum and its limbic connectivity mediate abnormal anticipatory reward processing in obesity. PLoS One 7: e31089, 2012.
258. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 5: 566-572, 2002.
259. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8: 1376-1382, 2002.
260. Ohara T, Doi Y, Ninomiya T, Hirakawa Y, Hata J, Iwaki T, Kanba S, Kiyohara Y. Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology 77: 1126-1134, 2011.
261. Oitzl MS, Champagne DL, van der Veen R, de Kloet ER. Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci Biobehav Rev 34: 853-866, 2010.
262. Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I, Accili D. Transgenic rescue of insulin receptor-deficient mice. J Clin Invest 114: 214-223, 2004.
263. Olivo G, Wiemerslage L, Nilsson EK, Solstrand Dahlberg L, Larsen AL, Olaya Bucaro M, Gustafsson VP, Titova OE, Bandstein M, Larsson EM, Benedict C, Brooks SJ, Schioth HB. Resting-state brain and the FTO obesity risk allele: default mode, sensorimotor, and salience network connectivity underlying different somatosensory integration and reward processing between genotypes. Front Hum Neurosci 10: 52, 2016.
264. Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz L, Uhl GR. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann NY Acad Sci 1074: 514-536, 2006.
265. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39: 1392-1397, 1996.
266. Ott V, Benedict C, Schultes B, Born J, Hallschmid M. Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism. Diabetes Obes Metab 14: 214-221, 2012.
267. Ott V, Lehnert H, Staub J, Wonne K, Born J, Hallschmid M. Central nervous insulin administration does not potentiate the acute glucoregulatory impact of concurrent mild hyperinsulinemia. Diabetes 64: 760-765, 2015.
268. Page KA, Arora J, Qiu M, Relwani R, Constable RT, Sherwin RS. Small decrements in systemic glucose provoke increases in hypothalamic blood flow prior to the release of counterregulatory hormones. Diabetes 58: 448-452, 2009.
269. Page KA, Chan O, Arora J, Belfort-Deaguiar R, Dzuira J, Roehmholdt B, Cline GW, Naik S, Sinha R, Constable RT, Sherwin RS. Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. JAMA 309: 63-70, 2013.
270. Page KA, Seo D, Belfort-DeAguiar R, Lacadie C, Dzuira J, Naik S, Amarnath S, Constable RT, Sherwin RS, Sinha R. Circulating glucose levels modulate neural control of desire for high-calorie foods in humans. J Clin Invest 121: 4161-4169, 2011.
271. Parachikova A, Agadjanyan MG, Cribbs DH, Blurton-Jones M, Perreau V, Rogers J, Beach TG, Cotman CW. Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging 28: 1821-1833, 2007.
272. Paranjape SA, Chan O, Zhu W, Horblitt AM, Grillo CA, Wilson S, Reagan L, Sherwin RS. Chronic reduction of insulin receptors in the ventromedial hypothalamus produces glucose intolerance and islet dysfunction in the absence of weight gain. Am J Physiol Endocrinol Metab 301: E978-E983, 2011.
273. Park CR, Johnson LH. Effect of insulin on transport of glucose and galactose into cells of rat muscle and brain. Am J Physiol 182: 17-23, 1955.
274. Pedersen J. Diabetes and Pregnancy: Blood Sugar of Newborn Infants. Copenhagen: Danish Science Press, 1952.
275. Perrin C, Knauf C, Burcelin R. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-car- boxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis. Endocrinology 145: 4025-4033, 2004.
276. Plagemann A. A matter of insulin: developmental programming of body weight regulation. J Matern Fetal Neonatal Med 21: 143-148, 2008.
277. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L, Rossetti L. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434: 1026-1031, 2005.
278. Porte D Jr, Baskin DG, Schwartz MW. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54: 1264-1276, 2005.
279. Preissl H, Lowery CL, Eswaran H. Fetal magnetoencephalography: viewing the developing brain in utero. Int Rev Neurobiol 68: 1-23, 2005.
280. Puig J, Blasco G, Daunis IEJ, Molina X, Xifra G, Ricart W, Pedraza S, Fernandez-Aranda F, Fernandez-Real JM. Hypothalamic damage is associated with inflammatory markers and worse cognitive performance in obese subjects. J Clin Endocrinol Metab 100: E276-E281, 2015.
281. Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med 362: 329-344, 2010.
282. Ragvin A, Moro E, Fredman D, Navratilova P, Drivenes O, Engstrom PG, Alonso ME, de la Calle Mustienes E, Gomez Skarmeta JL, Tavares MJ, Casares F, Manzanares M, van Heyningen V, Molven A, Njolstad PR, Argenton F, Lenhard B, Becker TS. Longrange gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3. Proc Natl Acad Sci USA 107: 775-780, 2010.
283. Rahmouni K, Morgan DA, Morgan GM, Liu X, Sigmund CD, Mark AL, Haynes WG. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Invest 114: 652-658, 2004.
284. Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, Kuller LH, Hua X, Leow AD, Toga AW, Thompson PM. Brain structure and obesity. Hum Brain Mapp 31: 353-364, 2010.
285. Ramnanan CJ, Edgerton DS, Cherrington AD. Evidence against a physiologic role for acute changes in CNS insulin action in the rapid regulation of hepatic glucose production. Cell Metab 15: 656-664, 2012.
286. Rasch B, Born J. About sleep’s role in memory. Physiol Rev 93: 681-766, 2013.
287. Rasgon NL, Kenna HA, Wroolie TE, Kelley R, Silverman D, Brooks J, Williams KE, Powers BN, Hallmayer J, Reiss A. Insulin resistance and hippocampal volume in women at risk for Alzheimer’s disease. Neurobiol Aging 32: 1942-1948, 2011.
288. Reger MA, Watson GS, Frey WH, 2nd Baker LD, Cholerton B, Keeling ML, Belongia DA, Fishel MA, Plymate SR, Schellenberg GD, Cherrier MM, Craft S. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging 27: 451-458, 2006.
289. Reger MA, Watson GS, Green PS, Baker LD, Cholerton B, Fishel MA, Plymate SR, Cherrier MM, Schellenberg GD, Frey WH 2nd, Craft S. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory- impaired older adults. J Alzheimers Dis 13: 323-331, 2008.
290. Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymate SR, Breitner JC, DeGroodt W, Mehta P, Craft S. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 70: 440-448, 2008.
291. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D. Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334: 752-758, 1996.
292. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia. Proc Natl Acad Sci USA 101: 284-289, 2004.
293. Ren H, Lu TY, McGraw TE, Accili D. Anorexia and impaired glucose metabolism in mice with hypothalamic ablation of Glut4 neurons. Diabetes 64: 405-417, 2015.
294. Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: link to brain reductions in acetylcholine. J Alzheimers Dis 8: 247-268, 2005.
295. Roberts RO, Knopman DS, Cha RH, Mielke MM, Pankratz VS, Boeve BF, Kantarci K, Geda YE, Jack CR Jr, Petersen RC, Lowe VJ. Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation. J Nucl Med 55: 759-764, 2014.
296. Rolls ET. The functions of the orbitofrontal cortex. Brain Cogn 55: 11-29, 2004.
297. Roth CL, Hinney A, Schur EA, Elfers CT, Reinehr T. Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention. BMC Pediatr 13: 197, 2013.
298. Rusinek H, Ha J, Yau PL, Storey P, Tirsi A, Tsui WH, Frosch O, Azova S, Convit A. Cerebral perfusion in insulin resistance and type 2 diabetes. J Cereb Blood Flow Metab 35: 95-102, 2015.
299. Russell-Jones D, Danne T, Hermansen K, Niswender K, Robertson K, Thalange N, Vasselli JR, Yildiz B, Häring HU. Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake? Diabetes Obes Metab 17: 919-927, 2015.
300. Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes- causes, effects and coping strategies. Diabetes Obes Metab 9: 799-812, 2007.
301. Rutgers DR, Klijn CJ, Kappelle LJ, van der Grond J. Cerebral metabolic changes in patients with a symptomatic occlusion of the internal carotid artery: a longitudinal 1H magnetic resonance spectroscopy study. J Magn Reson Imaging 11: 279-286, 2000.
302. Sabri O, Hellwig D, Schreckenberger M, Schneider R, Kaiser HJ, Wagenknecht G, Mull M, Buell U. Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow. Nucl Med Commun 21: 19-29, 2000.
303. Sanchez-Alavez M, Tabarean IV, Osborn O, Mitsukawa K, Schaefer J, Dubins J, Holmberg KH, Klein I, Klaus J, Gomez LF, Kolb H, Secrest J, Jochems J, Myashiro K, Buckley P, Hadcock JR, Eberwine J, Conti B, Bartfai T. Insulin causes hyperthermia by direct inhibition of warm-sensitive neurons. Diabetes 59: 43-50, 2010.
304. Saper CB. The Hypothalamus. San Diego, CA: Academic, 1990.
305. Saraiva LM, Seixas da Silva GS, Galina A, da-Silva WS, Klein WL, Ferreira ST, De Felice FG. Amyloid-beta triggers the release of neuronal hexokinase 1 from mitochondria. PLoS One 5: e15230, 2010.
306. Sartorius T, Peter A, Heni M, Maetzler W, Fritsche A, Häring HU, Hennige AM. The brain response to peripheral insulin declines with age: a contribution of the bloodbrain barrier? PLoS One 10: e0126804, 2015.
307. Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H, Iwamoto T. Efficacy of PPARgamma agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging 32: 1626-1633, 2011.
308. Sauseng P, Klimesch W, Doppelmayr M, Hanslmayr S, Schabus M, Gruber WR. Theta coupling in the human electroencephalogram during a working memory task. Neurosci Lett 354: 123-126, 2004.
309. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C, Medical Research Council Cognitive Function and Ageing Study. Age, neuropathology, and dementia. N Engl J Med 360: 2302-2309, 2009.
310. Scherer T, Buettner C. Yin and Yang of hypothalamic insulin and leptin signaling in regulating white adipose tissue metabolism. Rev Endocr Metab Disord 12: 235-243, 2011.
311. Scherer T, O’Hare J, Diggs-Andrews K, Schweiger M, Cheng B, Lindtner C, Zielinski E, Vempati P, Su K, Dighe S, Milsom T, Puchowicz M, Scheja L, Zechner R, Fisher SJ, Previs SF, Buettner C. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab 13: 183-194, 2011.
312. Schilling TM, Ferreira de Sa DS, Westerhausen R, Strelzyk F, Larra MF, Hallschmid M, Savaskan E, Oitzl MS, Busch HP, Naumann E, Schachinger H. Intranasal insulin increases regional cerebral blood flow in the insular cortex in men independently of cortisol manipulation. Hum Brain Mapp 35: 1944-1956, 2014.
313. Schmidt H, Kern W, Giese R, Hallschmid M, Enders A. Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial. J Med Genet 46: 217-222, 2009.
314. Scholtz S, Miras AD, Chhina N, Prechtl CG, Sleeth ML, Daud NM, Ismail NA, Durighel G, Ahmed AR, Olbers T, Vincent RP, Alaghband-Zadeh J, Ghatei MA, Waldman AD, Frost GS, Bell JD, le Roux CW, Goldstone AP. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut 63: 891-902, 2014.
315. Schwartz MW, Figlewicz DF, Kahn SE, Baskin DG, Greenwood MR, PorteDJr. Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats. Peptides 11: 467-472, 1990.
316. Schwartz MW, Seeley RJ, Tschop MH, Woods SC, Morton GJ, Myers MG, D’Alessio D. Cooperation between brain and islet in glucose homeostasis and diabetes. Nature 503: 59-66, 2013.
317. Seaquist ER. The impact of diabetes on cerebral structure and function. Psychosom Med 77: 616-621, 2015.
318. Seaquist ER, Chen W, Benedict LE, Ugurbil K, Kwag JH, Zhu XH, Nelson CA. Insulin reduces the BOLD response but is without effect on the VEP during presentation of a visual task in humans. J Cereb Blood Flow Metab 27: 154-160, 2007.
319. Seaquist ER, Damberg GS, Tkac I, Gruetter R. The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes 50: 2203-2209, 2001.
320. Selkoe DJ. The molecular pathology of Alzheimer’s disease. Neuron 6: 487-498, 1991.
321. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15: 2099-2111, 2001.
322. Sevgi M, Rigoux L, Kuhn AB, Mauer J, Schilbach L, Hess ME, Gruendler TO, Ullsperger M, Stephan KE, Bruning JC, Tittgemeyer M. An obesity-predisposing variant of the FTO gene regulates D2R-dependent reward learning. J Neurosci 35: 12584-12592, 2015.
323. Shah GN, Mooradian AD. Age-related changes in the blood-brain barrier. Exp Gerontol 32: 501-519, 1997.
324. Sheline YI, Raichle ME. Resting state functional connectivity in preclinical Alzheimer’s disease. Biol Psychiatry 74: 340-347, 2013.
325. Shemesh E, Rudich A, Harman-Boehm I, Cukierman-Yaffe T. Effect of intranasal insulin on cognitive function: a systematic review. J Clin Endocrinol Metab 97: 366-376, 2011.
326. Siep N, Roefs A, Roebroeck A, Havermans R, Bonte ML, Jansen A. Hunger is the best spice: an fMRI study of the effects of attention, hunger and calorie content on food reward processing in the amygdala and orbitofrontal cortex. Behav Brain Res 198: 149-158, 2009.
327. Singh-Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG. Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol 28: 1556-1562, 2008.
328. Sinha R, Jastreboff AM. Stress as a common risk factor for obesity and addiction. Biol Psychiatry 73: 827-835, 2013.
329. Sisley S, Gutierrez-Aguilar R, Scott M, D’Alessio DA, Sandoval DA, Seeley RJ. Neuronal GLP1R mediates liraglutide’s anorectic but not glucose-lowering effect. J Clin Invest 124: 2456-2463, 2014.
330. Smeets PA, de Graaf C, Stafleu A, van Osch MJ, van der Grond J. Functional MRI of human hypothalamic responses following glucose ingestion. Neuroimage 24: 363-368, 2005.
331. Smeets PA, Vidarsdottir S, de Graaf C, Stafleu A, van Osch MJ, Viergever MA, Pijl H, van der Grond J. Oral glucose intake inhibits hypothalamic neuronal activity more effectively than glucose infusion. Am J Physiol Endocrinol Metab 293: E754-E758, 2007.
332. Smemo S, Tena JJ, Kim KH, Gamazon ER, Sakabe NJ, Gomez-Marin C, Aneas I, Credidio FL, Sobreira DR, Wasserman NF, Lee JH, Puviindran V, Tam D, Shen M, Son JE, Vakili NA, Sung HK, Naranjo S, Acemel RD, Manzanares M, Nagy A, Cox NJ, Hui CC, Gomez-Skarmeta JL, Nobrega MA. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507: 371-375, 2014.
333. Sobngwi E, Boudou P, Mauvais-Jarvis F, Leblanc H, Velho G, Vexiau P, Porcher R, Hadjadj S, Pratley R, Tataranni PA, Calvo F, Gautier JF. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet 361: 1861-1865, 2003.
334. Speakman JR. The "fat mass and obesity related" (FTO) gene: mechanisms of impact on obesity and energy balance. Curr Obes Rep 4: 73-91, 2015.
335. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease-is this type 3 diabetes? J Alzheimers Dis 7: 63-80, 2005.
336. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168: 1609-1616, 2008.
337. Stingl KT, Kullmann S, Ketterer C, Heni M, Häring HU, Fritsche A, Preissl H. Neuronal correlates of reduced memory performance in overweight subjects. Neuroimage 60: 362-369, 2011.
338. Stingl KT, Rogic M, Stingl K, Canova C, Tschritter O, Braun C, Fritsche A, Preissl H. The temporal sequence of magnetic brain activity for food categorization and memorization- an exploratory study. Neuroimage 52: 1584-1591, 2010.
339. Stralfors P, Bjorgell P, Belfrage P. Hormonal regulation of hormone-sensitive lipase in intact adipocytes: identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin. Proc Natl Acad Sci USA 81: 3317-3321, 1984.
340. Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, Herrmann N. A metaanalysis of cytokines in Alzheimer’s disease. Biol Psychiatry 68: 930-941, 2010.
341. Talbot K. Brain insulin resistance in Alzheimer’s disease and its potential treatment with GLP-1 analogs. Neurodegenerative Dis Management 4: 31-40, 2014.
342. Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122: 1316-1338, 2012.
343. Tan ZS, Beiser AS, Fox CS, Au R, Himali JJ, Debette S, Decarli C, Vasan RS, Wolf PA, Seshadri S. Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study. Diabetes Care 34: 1766-1770, 2011.
344. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nature Rev Mol Cell Biol 7: 85-96, 2006.
345. Tataranni PA, Gautier JF, Chen K, Uecker A, Bandy D, Salbe AD, Pratley RE, Lawson M, Reiman EM, Ravussin E. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci USA 96: 4569-4574, 1999.
346. Teeuwisse WM, Widya RL, Paulides M, Lamb HJ, Smit JW, de Roos A, van Buchem MA, Pijl H, van der Grond J. Short-term caloric restriction normalizes hypothalamic neuronal responsiveness to glucose ingestion in patients with type 2 diabetes. Diabetes 61: 3255-3259, 2012.
347. Ten Kulve JS, Veltman DJ, van Bloemendaal L, Barkhof F, Deacon CF, Holst JJ, Konrad RJ, Sloan JH, Drent ML, Diamant M, Ijzerman RG. Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes. Diabetologia 58: 2688-2698, 2015.
348. Thaler JP, Yi CX, Schur EA, Guyenet SJ, Hwang BH, Dietrich MO, Zhao X, Sarruf DA, Izgur V, Maravilla KR, Nguyen HT, Fischer JD, Matsen ME, Wisse BE, Morton GJ, Horvath TL, Baskin DG, Tschop MH, Schwartz MW. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 122: 153-162, 2011.
349. Thambisetty M, Beason-Held LL, An Y, Kraut M, Metter J, Egan J, Ferrucci L, O’Brien R, Resnick SM. Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging. Neurobiol Aging 34: 2271-2276, 2013.
350. Thambisetty M, Jeffrey Metter E, Yang A, Dolan H, Marano C, Zonderman AB, Troncoso JC, Zhou Y, Wong DF, Ferrucci L, Egan J, Resnick SM, O’Brien RJ. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol 70: 1167-1172, 2013.
351. Toepel U, Knebel JF, Hudry J, le Coutre J, Murray MM. The brain tracks the energetic value in food images. Neuroimage 44: 967-974, 2009.
352. Tomasi D, Volkow ND. Striatocortical pathway dysfunction in addiction and obesity: differences and similarities. Crit Rev Biochem Mol Biol 48: 1-19, 2013.
353. Tomasi T, Sledz D, Wales JK, Recant L. Insulin half-life in normal and diabetic subjects. Revue de Neuropsychiatrie Infantile et d’Hygiene Mentale de l’Enfance 14: 315-317, 1966.
354. Torsoni MA, Carvalheira JB, Pereira-Da-Silva M, de Carvalho-Filho MA, Saad MJ, Velloso LA. Molecular and functional resistance to insulin in hypothalamus of rats exposed to cold. Am J Physiol Endocrinol Metab 285: E216-E223, 2003.
355. Townsend M, Mehta T, Selkoe DJ. Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem 282: 33305-33312, 2007.
356. Tribl G, Howorka K, Heger G, Anderer P, Thoma H, Zeitlhofer J. EEG topography during insulin-induced hypoglycemia in patients with insulin-dependent diabetes mellitus. Eur Neurol 36: 303-309, 1996.
357. Tschritter O, Haupt A, Preissl H, Ketterer C, Hennige AM, Sartorius T, Machicao F, Fritsche A, Häring HU. An obesity risk SNP (rs17782313) near the MC4R gene is associated with cerebrocortical insulin resistance in humans. J Obes 2011: 283153, 2011.
358. Tschritter O, Hennige AM, Preissl H, Grichisch Y, Kirchhoff K, Kantartzis K, Machicao F, Fritsche A, Häring HU. Insulin effects on beta and theta activity in the human brain are differentially affected by ageing. Diabetologia 52: 169-171, 2009.
359. Tschritter O, Hennige AM, Preissl H, Porubska K, Schafer SA, Lutzenberger W, Machicao F, Birbaumer N, Fritsche A, Häring HU. Cerebrocortical beta activity in overweight humans responds to insulin detemir. PLoS One 2: e1196, 2007.
360. Tschritter O, Preissl H, Hennige AM, Sartorius T, Grichisch Y, Stefan N, Guthoff M, Dusing S, Machann J, Schleicher E, Cegan A, Birbaumer N, Fritsche A, Häring HU. The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified Fatty acids. J Clin Endocrinol Metab 94: 4600-4607, 2009.
361. Tschritter O, Preissl H, Hennige AM, Sartorius T, Stingl KT, Heni M, Ketterer C, Stefan N, Machann J, Schleicher E, Fritsche A, Häring HU. High cerebral insulin sensitivity is associated with loss of body fat during lifestyle intervention. Diabetologia 55: 175-182, 2011.
362. Tschritter O, Preissl H, Hennige AM, Stumvoll M, Porubska K, Frost R, Marx H, Klosel B, Lutzenberger W, Birbaumer N, Häring HU, Fritsche A. The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study. Proc Natl Acad Sci USA 103: 12103-12108, 2006.
363. Tschritter O, Preissl H, Yokoyama Y, Machicao F, Häring HU, Fritsche A. Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans. Diabetologia 50: 2602-2603, 2007.
364. Tuulari JJ, Karlsson HK, Hirvonen J, Hannukainen JC, Bucci M, Helmio M, Ovaska J, Soinio M, Salminen P, Savisto N, Nummenmaa L, Nuutila P. Weight loss after bariatric surgery reverses insulin-induced increases in brain glucose metabolism of the morbidly obese. Diabetes 62: 2747-2751, 2013.
365. Unger JW, Livingston JN, Moss AM. Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol 36: 343-362, 1991.
366. Ursache A, Wedin W, Tirsi A, Convit A. Preliminary evidence for obesity and elevations in fasting insulin mediating associations between cortisol awakening response and hippocampal volumes and frontal atrophy. Psychoneuroendocrinology 37: 1270-1276, 2012.
367. Van Bloemendaal L, Ijzerman RG, Ten Kulve JS, Barkhof F, Konrad RJ, Drent ML, Veltman DJ, Diamant M. GLP-1 receptor activation modulates appetite- and rewardrelated brain areas in humans. Diabetes 63: 2688-2698, 2014.
368. Van Bloemendaal L, Ten Kulve JS, la Fleur SE, Ijzerman RG, Diamant M. Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS. J Endocrinol 221: T1-T16, 2014.
369. Van de Sande-Lee S, Pereira FR, Cintra DE, Fernandes PT, Cardoso AR, Garlipp CR, Chaim EA, Pareja JC, Geloneze B, Li LM, Cendes F, Velloso LA. Partial reversibility of hypothalamic dysfunction and changes in brain activity after body mass reduction in obese subjects. Diabetes 60: 1699-1704, 2011.
370. Van den Berg E, Reijmer YD, de Bresser J, Kessels RP, Kappelle LJ, Biessels GJ. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia 53: 58-65, 2009.
371. Van der Laan LN, de Ridder DT, Viergever MA, Smeets PA. The first taste is always with the eyes: a meta-analysis on the neural correlates of processing visual food cues. Neuroimage 55: 296-303, 2011.
372. Van Golen LW, Huisman MC, Ijzerman RG, Hoetjes NJ, Schwarte LA, Lammertsma AA, Diamant M. Cerebral blood flow and glucose metabolism measured with positron emission tomography are decreased in human type 1 diabetes. Diabetes 62: 2898-2904, 2013.
373. Van Golen LW, Ijzerman RG, Huisman MC, Hensbergen JF, Hoogma RP, Drent ML, Lammertsma AA, Diamant M. Cerebral blood flow and glucose metabolism in appetite- related brain regions in type 1 diabetic patients after treatment with insulin detemir and NPH insulin: a randomized-controlled crossover trial. Diabetes Care 36: 4050-4056, 2013.
374. Van Golen LW, Veltman DJ, RGIJ, Deijen JB, Heijboer AC, Barkhof F, Drent ML, Diamant M. Effects of insulin detemir and NPH insulin on body weight and appetiteregulating brain regions in human type 1 diabetes: a randomized controlled trial. PLoS One 9: e94483, 2014.
375. Van Houten M, Posner BI, Kopriwa BM, Brawer JR. Insulin-binding sites in the rat brain: in vivo localization to the circumventricular organs by quantitative radioautography. Endocrinology 105: 666-673, 1979.
376. Van Vugt DA, Krzemien A, Alsaadi H, Frank TC, Reid RL. Glucose-induced inhibition of the appetitive brain response to visual food cues in polycystic ovary syndrome patients. Brain Res 1558: 44-56, 2014.
377. Verdile G, Fuller SJ, Martins RN. The role of type 2 diabetes in neurodegeneration. Neurobiol Dis 84: 22-38, 2015.
378. Vidarsdottir S, Smeets PA, Eichelsheim DL, van Osch MJ, Viergever MA, Romijn JA, van der Grond J, Pijl H. Glucose ingestion fails to inhibit hypothalamic neuronal activity in patients with type 2 diabetes. Diabetes 56: 2547-2550, 2007.
379. Vogt MC, Bruning JC. CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age. Trends Endocrinol Metab 24: 76-84, 2013.
380. Vogt MC, Paeger L, Hess S, Steculorum SM, Awazawa M, Hampel B, Neupert S, Nicholls HT, Mauer J, Hausen AC, Predel R, Kloppenburg P, Horvath TL, Bruning JC. Neonatal insulin action impairs hypothalamic neurocircuit formation in response to maternal high-fat feeding. Cell 156: 495-509, 2014.
381. Volkow ND, Wang GJ, Tomasi D, Baler RD. The addictive dimensionality of obesity. Biol Psychiatry 73: 811-818, 2013.
382. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697-738, 2000.
383. Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, Kahn SE, Keeling ML, Craft S. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 13: 950-958, 2005.
384. Weiss PA, Hofmann H, Purstner P, Winter R, Lichtenegger W. Fetal insulin balance: gestational diabetes and postpartal screening. Obstet Gynecol 64: 65-68, 1984.
385. White MF. Regulating insulin signaling and beta-cell function through IRS proteins. Can J Physiol Pharmacol 84: 725-737, 2006.
386. White MF, Kahn CR. The insulin signaling system. J Biol Chem 269: 1-4, 1994.
387. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301: 1565-1572, 2009.
388. WHO. Obesity and overweight. World Health Organization, available at: http:// www.who.int/mediacentre/factsheets/fs311/en/, 2015.
389. Wiemerslage L, Nilsson EK, Solstrand Dahlberg L, Ence-Eriksson F, Castillo S, Larsen AL, Bylund SB, Hogenkamp PS, Olivo G, Bandstein M, Titova OE, Larsson EM, Benedict C, Brooks SJ, Schioth HB. An obesity-associated risk allele within the FTO gene affects brain activity for areas important for emotion, impulse control, and reward in response to food images. Eur J Neurosci 43: 1173-1180, 2016.
390. Willette AA, Johnson SC, Birdsill AC, Sager MA, Christian B, Baker LD, Craft S, Oh J, Statz E, Hermann BP, Jonaitis EM, Koscik RL, La Rue A, Asthana S, Bendlin BB. Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement 11: e501504-510, 2015.
391. Willette AA, Modanlo N, Kapogiannis D, Alzheimer’s Disease Neuroimaging Initiative. Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease. Diabetes 64: 1933-1940, 2015.
392. Willette AA, Xu G, Johnson SC, Birdsill AC, Jonaitis EM, Sager MA, Hermann BP, La Rue A, Asthana S, Bendlin BB. Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care 36: 443-449, 2013.
393. Williams KW, Elmquist JK. From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behavior. Nat Neurosci 15: 1350-1355, 2012.
394. Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science 296: 678-682, 2002.
395. Winkler JK, Woehning A, Schultz JH, Brune M, Beaton N, Challa TD, Minkova S, Roeder E, Nawroth PP, Friederich HC, Wolfrum C, Rudofsky G. TaqIA polymorphism in dopamine D2 receptor gene complicates weight maintenance in younger obese patients. Nutrition 28: 996-1001, 2012.
396. Wolf PA, Beiser A, Elias MF, Au R, Vasan RS, Seshadri S. Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res 4: 111-116, 2007.
397. Woods SC, Lotter EC, McKay LD, Porte D Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282: 503-505, 1979.
398. Woods SC, Porte D Jr. Effect of intracisternal insulin on plasma glucose and insulin in the dog. Diabetes 24: 905-909, 1975.
399. Wozniak M, Rydzewski B, Baker SP, Raizada MK. The cellular and physiological actions of insulin in the central nervous system. Neurochem Int 22: 1-10, 1993.
400. Xia W, Wang S, Spaeth AM, Rao H, Wang P, Yang Y, Huang R, Cai R, Sun H. Insulin resistance-associated interhemispheric functional connectivity alterations in T2DM: a resting-state fMRI Study. BioMed Res Int 2015: 719076, 2015.
401. Zhang H, Hao Y, Manor B, Novak P, Milberg W, Zhang J, Fang J, Novak V. Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes. Diabetes 64: 1025-1034, 2015.
402. Zhao WQ, Alkon DL. Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 177: 125-134, 2001.
403. Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ, Krafft GA, Klein WL. Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 22: 246-260, 2008.
404. Zhao Z, Xiang Z, Haroutunian V, Buxbaum JD, Stetka B, Pasinetti GM. Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer’s disease. Neurobiol Aging 28: 824-830, 2007.